ArticleDiabetes, obesity & metabolism2025

Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States.

Yunwen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.